Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator
Ligand Pharmaceuticals Inc. · PHARMACEUTICAL PREPARATIONS · Now $229.78
-5.1% in 3d after detection
Post-detection moves
1h
—
1d
-3.9%
3d
-5.1%
7d
-3.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS